Vital Sign | Placebo Wk 0 | Placebo Wk 8 | A Wk. 0 | A Wk. 8 | B Wk. 0 | B Wk. 8 | C Wk. 0 | C Wk. 8 |
---|
Pulse Rate
| 80.3 ± 1.3 | 76.9 ± 1.1 | 79.1 ± 1.3 | 74.7 ± 0.9 | 80.7 ± 1.3 | 76.1 ± 1.2 | 78.6 ± 0.9 | 76.6 ± 0.9 |
Systolic BP
| 128 ± 1 | 130 ± 2 | 129 ± 2 | 130 ± 3 | 132 ± 2 | 129 ± 3 * | 129 ± 1 | 128 ± 2 |
Diastolic BP
| 83 ± 1 | 86 ± 1 | 82 ± 1 | 82 ± 1 | 83 ± 1 | 82 ± 1 | 80 ± 1 | 80 ± 2 |
Respiration Rate
| 19.5 ± 0.7 | 19.9 ± 0.7 | 19.2 ± 0.6 | 18.9 ± 0.4 | 19.7 ± 0.7 | 19.4 ± 0.8 | 20.2 ± 0.5 | 18.5 ± 0.5 * |
- Data expressed as a mean ± sem. Units of measure were: Pulse rate (beats per min), systolic and diastolic blood pressure (mm Hg), respiration rate (breaths per minute). Group A = High dose sierrasil (n = 20), Group B = Low dose sierrasil (n = 21), Group C = Low dose sierrasil + cat's claw extract (n = 25), placebo n = 22. Pulse rate and respiration rate are given as the rate per minute and blood pressure is expressed in mm Hg. Using unpaired t test, the following descriptors describe a significant difference from baseline, *p < 0.05.